2021
DOI: 10.1039/d0lc00639d
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic organ-on-a-chip model of the outer blood–retinal barrier with clinically relevant read-outs for tissue permeability and vascular structure

Abstract: This organ-on-a-chip device of the outer blood retinal barrier will allow future studies of complex disease mechanisms and treatments of visual disorders using clinically relevant endpoints in vitro.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
52
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 54 publications
(52 citation statements)
references
References 61 publications
0
52
0
Order By: Relevance
“…Microfluidic technologies are well-suited for the study of retinal degenerative diseases, as well as the development of novel therapies, by developing models that mimic the physiological environment at the retinal microscale. Organ-on-a-chip platforms (reviewed in [ 61 , 62 ]) have been recently developed by multiple groups using retinal stem and progenitor cells (SCs) [ 63 , 64 , 65 , 66 ] or organoids [ 67 , 68 , 69 , 70 ] to recapitulate the retinal cellular niche in both healthy and disease states. Some existing systems use 3D, organotypic systems that integrate explanted retina to measure tissue viability and cytotoxicity [ 71 ], while others examine the delivery of therapeutic compounds [ 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…Microfluidic technologies are well-suited for the study of retinal degenerative diseases, as well as the development of novel therapies, by developing models that mimic the physiological environment at the retinal microscale. Organ-on-a-chip platforms (reviewed in [ 61 , 62 ]) have been recently developed by multiple groups using retinal stem and progenitor cells (SCs) [ 63 , 64 , 65 , 66 ] or organoids [ 67 , 68 , 69 , 70 ] to recapitulate the retinal cellular niche in both healthy and disease states. Some existing systems use 3D, organotypic systems that integrate explanted retina to measure tissue viability and cytotoxicity [ 71 ], while others examine the delivery of therapeutic compounds [ 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…150 This unique model enabled 3D co-cultures of monolayers of human retinal pigment epithelium cells with human endothelial cells lining a microvessel. 151 In addition, microvessels demonstrated a well-defined geometry and physiological permeability, which increased in a dose-dependent manner with oxidative stress exposure, making this a useful model for the study of age-related macular degeneration.…”
Section: Functional Readoutsmentioning
confidence: 99%
“…The addition of these cells to retinal organoids would likely require assembloid type technology to bring together cells from different developmental lineages, which was pioneered in brain organoids [ 177 ]. Recently, a model of outer-blood-retinal barrier on-a-chip has been described combining RPE and endothelial cells in a microfluidic chamber [ 178 ].…”
Section: Introductionmentioning
confidence: 99%